Results 151 to 160 of about 97,554 (214)

Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants

European Journal of Haematology, EarlyView.
ABSTRACT Thrombotic events, particularly venous thromboembolism (VTE), are a significant source of morbidity and mortality among patients with hematologic malignancies. These patients face unique challenges due to treatment‐related complications such as thrombocytopenia, coagulopathy, and heightened bleeding risk.
Mario Biglietto, Silvia Sorella, Erminia Baldacci, Massimo Breccia, Sabina Chiaretti, Marcello Capriata, Livia Donzelli, Gianna Maria D'Elia, Salvatore Giacomo Morano, Ilaria Del Giudice, Maurizio Martelli, Cristina Santoro, Antonio Chistolini   +12 more
wiley   +1 more source

Predictive factors for poor mobilization in autologous stem cell transplant: a multivariate model. [PDF]

Hematol Transfus Cell Ther
Bagherian M, Jalili M, Mohammadi S, Kamranzadeh H, Mousavi SA, Shamshiri A, Vaezi M, Ferdowsi S.   +7 more
europepmc   +1 more source

Global, regional, and national burden of lymphoma from 1990 to 2021: a comprehensive analysis based on the global burden of disease study 1990-2021. [PDF]

Eur J Med Res
Shi Y, Cao T, Xu Y, Liu L, Wen H, Zhao Y, Sun J, Zheng X, Jin J, Tong H, Huang Y, Xie W.   +11 more
europepmc   +1 more source

Chronic pruritus treated with alendronate in bilateral striopallidodentate calcinosis associated with an SLC20A2 gene mutation

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Adrien Boyard, Florian Stéphan, Boris Chaumette, Mathilde Moreau, Laure Bleton, Nicolas Hornez, Steeve Genestet, Jérémy Betrand, Amélie Bourhis, Morgane Le Bon‐Jégo, Thierry Bienvenu, Camille Verebi, Laurent Misery   +12 more
wiley   +1 more source

Global trends in the burden of non-Hodgkin Lymphoma: a comprehensive analysis from 1990 to 2045. [PDF]

Cancer Causes Control
Wang S, Wang J, Lin J.
europepmc   +1 more source

Jaye DL, Feldman AL. ALK-negative anaplastic large cell lymphoma with JAK2 rearrangement mimicking classic Hodgkin lymphoma. Blood. 2023;141(17):2160.

Blood
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Fibrosis in Hodgkin and non-Hodgkin lymphomas

Pathology - Research and Practice, 2007
There is little quantitative information about the amount of fibrosis in lymphomas. The aim of the present study was to investigate the amount of fibrosis in lymphomas and to highlight the relationship between fibrosis and mast cells, the key players of fibrosis.
Ozkal, SERMİN, Tataroglu, Canten, Kargi, Aydanur, Aydin, Oezlem, SARIOĞLU, SÜLEN   +4 more
openaire   +3 more sources

Hodgkin’s disease and non-Hodgkin’s lymphoma

Current Opinion in Hematology, 1999
The development of new classification schemes and prognostic analyses for lymphomas has helped to identify patients at high risk for relapse who may benefit from intensification of primary therapy. Conventional salvage therapy for relapsed follicular or low-grade lymphomas now includes monoclonal antibody therapy.
R G, Bociek, J O, Armitage
openaire   +2 more sources